IQM Quantum (IQMX) Q3 2026 Earnings Call Transcript

IQM reported Q3 2026 revenue of EUR 8.9 million, up 51% year over year, and order intake of EUR 42.2 million, lifting backlog to EUR 102.5 million. It reiterated 2026 revenue guidance of EUR 42–47 million and order-intake guidance of EUR 65–75 million, while reporting EUR 260.4 million in cash and a runway into Q2 2028. Delivery and customer acceptance of the first 150-qubit systems remain key to guidance; management also cited a slight CESGA delivery delay into early 2027 and a Q3 operating loss of EUR 171.2 million, including EUR 127.1 million in noncash listing expense.

Analysis

Execution, not bookings, is the near-term equity driver. The key asymmetry is that customer acceptance can move reported revenue across quarter-end without changing contract value, while delivery costs and cash consumption continue. That makes the Q4 print unusually binary: a slip could pressure confidence in guidance and bring the stated runway into sharper focus; on-time acceptance would validate deployment capability, not yet establish repeatable unit economics. Over 1–3 months, track acceptance dates, cash burn and whether new orders replenish backlog as it converts. Over 6–18 months, larger error-correction projects could lift contract values but also lengthen conversion cycles and concentrate execution risk in a few multiyear programs.

The contrarian point: a large error-correction contract is evidence of willingness to fund a roadmap, not proof of useful commercial quantum advantage or attractive margins. The staged upgrade value is already within the announced contract, so do not treat each stage as incremental demand. Reported fidelity and user registrations are technical/ecosystem signals; the investment test is reliable system-level performance and customer acceptance at scale.

NVIDIA and AMD may benefit strategically from hybrid quantum/HPC integration, but the call provides no basis to underwrite material near-term earnings contribution. Infineon’s consortium role is similarly optionality, not a standalone catalyst. No compelling read-through trade in these larger suppliers.

Key Decisions for Investors

• For IQM Quantum Computers exposure, avoid adding ahead of the first 150-qubit customer acceptances; reassess after confirmation of acceptance and revenue recognition. Upside is execution credibility and backlog conversion; downside is a timing slip that damages guidance confidence while cash outflow continues. No price target without valuation and share-price data.
• Set an alert for the next results update: verify acceptance dates, revenue against guidance, operating cash flow excluding listing-related items, and any change to the stated runway. A further acceptance delay, weaker order intake, or faster normalized cash burn would falsify the improving-execution thesis.
• Do not buy AMD or NVIDIA solely on these integrations. Treat them as strategic ecosystem exposure until disclosed customer workloads, commercial economics, or revenue contribution make the link financially measurable.